RADiCAIT

RADiCAIT is a Boston-based AI medtech company spun out of Oxford University. Its core product, Insilico PET®, uses a generative deep neural network to synthesize PET-like functional imaging data from standard CT scans — eliminating the need for radioactive tracers, new hardware, or additional patient appointments. The technology targets cardiological, neurological, and oncological disease detection, staging, and treatment planning at scale. RADiCAIT emerged from stealth in October 2024 with $1.7 million in pre-seed financing. Founders include Dr. Seán Walsh (CEO), Dr. Regent Lee (CMIO, Oxford professor), and Dr. Sina Shahandeh (CTO).